337 related articles for article (PubMed ID: 21933565)
21. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
[TBL] [Abstract][Full Text] [Related]
22. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
23. Uterine surveillance of asymptomatic postmenopausal women taking tamoxifen.
Gardner FJ; Konje JC; Brown L; Khanna S; Bell SC; Taylor DJ; al-Azzawi F
Climacteric; 1998 Sep; 1(3):180-7. PubMed ID: 11907942
[TBL] [Abstract][Full Text] [Related]
24. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
[TBL] [Abstract][Full Text] [Related]
25. The role of hysteroscopy with eye-directed biopsy in postmenopausal women with uterine bleeding and endometrial atrophy.
Tinelli R; Tinelli FG; Cicinelli E; Malvasi A; Tinelli A
Menopause; 2008; 15(4 Pt 1):737-42. PubMed ID: 18202590
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
27. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
28. Hysteroscopic evaluation of the endometrium in postmenopausal women taking tamoxifen.
Ceci O; Bettocchi S; Marello F; Di Venere R; Pellegrino AR; Laricchia L; Vimercati A
J Am Assoc Gynecol Laparosc; 2000 May; 7(2):185-9. PubMed ID: 10806260
[TBL] [Abstract][Full Text] [Related]
29. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
30. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.
Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC
Menopause; 2010; 17(3):487-93. PubMed ID: 20464783
[TBL] [Abstract][Full Text] [Related]
31. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
[TBL] [Abstract][Full Text] [Related]
32. Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake.
Garuti G; Cellani F; Grossi F; Colonnelli M; Centinaio G; Luerti M
Gynecol Oncol; 2002 Sep; 86(3):323-9. PubMed ID: 12217755
[TBL] [Abstract][Full Text] [Related]
33. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
[TBL] [Abstract][Full Text] [Related]
34. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract][Full Text] [Related]
35. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
36. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.
Sinawat S; Chiyabutra T; Kleabkaew P
Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591
[TBL] [Abstract][Full Text] [Related]
37. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
Reslová T; Tosner J; Vávrová I; Resl M
Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
[TBL] [Abstract][Full Text] [Related]
38. Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study.
Sinawat S; Chiyabutra T
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S59-63. PubMed ID: 21218592
[TBL] [Abstract][Full Text] [Related]
39. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
[TBL] [Abstract][Full Text] [Related]
40. Transvaginal ultrasonography and hysteroscopy in the diagnosis of endometrial abnormalities.
Mortakis AE; Mavrelos K
J Am Assoc Gynecol Laparosc; 1997 Aug; 4(4):449-52. PubMed ID: 9224578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]